Brochure

Commercial Packaging And Distribution Services For Cell And Gene Therapies

Source: Thermo Fisher Scientific
GettyImages-155372946-cold-chain-cryopreservation-logistics

The cell and gene therapy market is about to reach a commercialization inflection point, with the FDA anticipating 10-20 new approvals per year through 2025¹. As innovators approach their commercial filing, it is vital to consider how the drug will be packaged, labeled, and distributed to hospital sites. Many questions regarding courier services or tertiary packaging and data loggers are addressed in clinical trials. However, the standards for commercial drug product are very specific, and your filing will need to demonstrate validated processes for every aspect of your logistics strategy, from labeling to shipping.

Discover how Patheon leverages 35+ years of experience and a global network to support the secondary packaging, labeling, and distribution of your life-saving cell or gene therapy.

access the Brochure!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Clinical Leader